603207 小方製藥
按盤價 
27.940 +2.540 (+10.000%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 9.441 | 17.833 | 22.630 | 42.765 | 58.251 |
| 總資產報酬率 ROA (%) | 8.291 | 15.707 | 19.410 | 34.632 | 41.252 |
| 投入資產回報率 ROIC (%) | 9.358 | 17.737 | 22.571 | 42.573 | 56.712 | 邊際利潤分析 |
| 銷售毛利率 (%) | 60.900 | 65.000 | 65.614 | 65.463 | 59.037 |
| 營業利潤率 (%) | 43.835 | 45.979 | 50.532 | 50.052 | 45.165 |
| 息稅前利潤/營業總收入 (%) | 42.978 | 45.338 | 49.205 | 49.950 | 44.937 |
| 淨利潤/營業總收入 (%) | 37.438 | 39.501 | 43.253 | 43.153 | 38.342 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 99.442 | 100.423 | 99.425 | 97.433 | 96.210 |
| 價值變動淨收益/利潤總額(%) | 0.000 | 0.000 | 0.007 | 0.950 | 1.442 |
| 營業外收支淨額/利潤總額(%) | -0.097 | -0.121 | -0.129 | 0.417 | -0.142 | 償債能力分析 |
| 流動比率 (X) | 5.547 | 5.876 | 6.137 | 3.420 | 3.644 |
| 速動比率 (X) | 5.171 | 5.403 | 5.868 | 3.043 | 3.009 |
| 資產負債率 (%) | 12.500 | 11.837 | 11.994 | 18.620 | 19.628 |
| 帶息債務/全部投入資本 (%) | 0.885 | 0.825 | 0.254 | 0.164 | 0.490 |
| 股東權益/帶息債務 (%) | 11,191.837 | 12,012.420 | 39,219.493 | 60,752.816 | 20,243.307 |
| 股東權益/負債合計 (%) | 700.004 | 744.836 | 733.730 | 437.052 | 409.475 |
| 利息保障倍數 (X) | -52.765 | -77.390 | -39.003 | -160.364 | -273.748 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 76.924 | 71.803 | 65.707 | 63.805 | 54.195 |
| 存貨周轉天數 (天) | 106.600 | 111.992 | 104.905 | 118.297 | 106.348 |
| 備註： | 即時報價更新時間為 02/09/2026 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
